ETHZilla is ramping up its Ethereum strategy with a $250 million stock buyback and a growing crypto treasury now worth $489 million.

Key Takeaways

  • ETHZilla authorized a $250 million stock repurchase plan that runs through June 2026
  • The company now holds 102,237 ETH purchased at an average of $3,948.72, valued at roughly $489 million
  • The move comes weeks after ETHZilla pivoted to crypto, rebranding from 180 Life Sciences and shifting its focus from biotech to Ethereum
  • Shares plunged nearly 30% after news of a potential 74.8 million convertible share offering, despite the firm’s growing ETH reserves

What Happened?

ETHZilla, formerly a biotechnology company, has taken another bold step in its new crypto-centric journey. The firm has authorized a massive $250 million stock buyback and disclosed significant Ethereum holdings now valued at $489 million. This marks a deepening of the company’s pivot into digital assets following its rebranding from 180 Life Sciences.

ETHZilla’s Growing Ethereum Strategy

ETHZilla has acquired 102,237 ETH at an average price of $3,948.72, totaling more than $403 million in expenditures. These holdings are now worth approximately $489 million at current market prices. The firm also holds an additional $215 million in cash equivalents, giving it substantial liquidity.

The newly announced stock repurchase program, authorized by the board and effective immediately, is set to run until June 30, 2026, or until the full $250 million allocation is exhausted. ETHZilla currently has around 165.4 million shares outstanding.

McAndrew Rudisill, Executive Chairman of ETHZilla, stated the repurchase demonstrates the company’s commitment to maximizing shareholder value while scaling its ETH reserves and exploring yield opportunities.

New Protocol and Staking Plans

ETHZilla also revealed the launch of its proprietary Electric Asset Protocol, aimed at generating higher yields from its crypto holdings. The company plans to stake its newly acquired ETH with Electric Capital to further enhance returns.

This initiative is part of a broader effort to differentiate ETHZilla’s ether treasury strategy from others, by combining long-term holding with yield-generation mechanisms.

Mounting Challenges and Risks

Despite the strategic pivot and growing crypto reserves, ETHZilla continues to face fundamental financial challenges. The company reported an accumulated deficit of over $141.5 million last year and continues to struggle with limited revenues and ongoing losses.

The stock price has also experienced volatility. ETHZilla shares fell nearly 30 percent following disclosure of a potential convertible share offering involving up to 74.8 million shares. The stock was trading around $3.15 at last update, down 4.5 percent.

Industry Comparisons and Risk Factors

ETHZilla joins a growing list of companies including BitMine Immersion Technologies, The Ether Machine, and SharpLink Gaming that have embraced crypto assets on their balance sheets.

Experts caution that this strategy carries significant risks. Leverage and concentrated ETH exposure could backfire if prices fall, especially for companies financing crypto purchases through loans, convertible notes, or equity dilution.

Mike Foy of Amina Bank warned that it is still too early to assess whether crypto treasury strategies are sustainable. Kadan Stadelmann of Komodo Platform pointed out the benefits of ETH-treasury firms over spot ETFs, especially in their ability to stake and earn DeFi yields, but acknowledged that overleveraging remains a major concern.

CoinLaw’s Takeaway

I’ve seen a lot of bold crypto plays, but ETHZilla’s rapid transformation from biotech to Ethereum-focused treasury is one of the most aggressive moves yet. In my experience, such pivots can pay off, but only when backed by clear strategy and risk control. Launching a $250 million buyback while holding nearly half a billion in ETH shows confidence, but the steep drop in share price after the convertible offering hints at investor caution. ETHZilla is gambling big, and whether this will be remembered as visionary or reckless depends heavily on ETH’s market trajectory and the firm’s ability to deliver on its protocol promises.

Kathleen Kinder

Kathleen Kinder

Senior Editor


Kathleen Kinder brings over 11 years of experience in the research industry, with deep expertise in finance, cryptocurrency, and insurance. At CoinLaw, she writes timely, reader-focused news articles and also serves as a senior editorial reviewer. Drawing on her background in B2B research, consumer insights, and executive interviews, she ensures every piece delivers clarity, accuracy, and real-world relevance.
Disclaimer: The content published on CoinLaw is intended solely for informational and educational purposes. It does not constitute financial, legal, or investment advice, nor does it reflect the views or recommendations of CoinLaw regarding the buying, selling, or holding of any assets. All investments carry risk, and you should conduct your own research or consult with a qualified advisor before making any financial decisions. You use the information on this website entirely at your own risk.

Reader Interactions

Leave a Comment

  • Banking
  • Compliance
  • Cryptocurrency
  • Finance
  • Investments